• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    XBiotech Pauses Rheumatology program

    GLOBENEWSWIRE

    XBiotech Study Suggests Breakthrough For Advanced Pancreatic Cancer

    GLOBENEWSWIRE

    XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

    GLOBENEWSWIRE

    Dr. Alan Kivitz to Chair XBiotech™s Natrunix Program in Rheumatoid Arthritis

    GLOBENEWSWIRE

    XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin

    GLOBENEWSWIRE

    XBiotech Announces Enrollment Completion of Ph II, Placebo Controlled

    GLOBENEWSWIRE

    XBiotech Announces First Patient Begins Novel Natrunix Therapy in PII RA Trial

    GLOBENEWSWIRE

    XBiotech Commences Tender Offer to Purchase $80,000,000 Worth of Its Shares

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.